Human papillomavirus DNA in plasma of patients with HPV16 DNA-positive uterine cervical cancer.
スポンサーリンク
概要
- 論文の詳細を見る
OBJECTIVES: The squamous cell carcinoma antigen is considered the most accurate serologic tumor marker for uterine cervical carcinoma. However, serum squamous cell carcinoma antigen levels were found to correlate significantly with clinical severity of atopic dermatitis and chronic renal failure. The present study was conducted in patients with human papillomavirus 16 DNA-positive uterine cervical cancer to determine the plasma level of human papillomavirus 16 DNA and the diagnostic values of plasma human papillomavirus DNA in these patients. METHODS: Forty-three human papillomavirus 16-positive patients with cervical intraepithelial neoplasia or uterine cervical squamous cell carcinoma were recruited in this study. The diagnosis was cervical cancer in 20 patients, high-grade squamous intraepithelial lesions in 21, low-grade squamous intraepithelial lesions in 1 and negative for intraepithelial lesion or malignancy in 3 patients. Before any treatment, blood samples were collected from all patients. For analysis of human papillomavirus DNA in plasma of patients with cervical cancer, quantitative polymerase chain reaction fluorescent assay for human papillomavirus 16 was performed using human papillomavirus 16 primers and SYBR Green dye using the LightCycler 480 SW1.5 apparatus. RESULTS: Plasma human papillomavirus 16 DNA was detected in only 30.0% of the patients with human papillomavirus 16-positive cervical cancer and in none of normal controls. The copy number of plasma human papillomavirus 16 DNA was higher in patients with invasive cancer than in those with cervical intraepithelial neoplasia (CIN3), micro-invasive cancer and in normal individuals. CONCLUSIONS: These results indicated that the plasma human papillomavirus DNA level could be potentially used as a marker of low-invasive cervical cancer tumors in patients with normal squamous cell carcinoma antigen levels before treatment.
論文 | ランダム
- 示-39 胃平滑筋肉腫に対する臨床的検討(第37回日本消化器外科学会総会)
- 333 Cholangiovenous reflux のメカニズム : シミュレーションによる考察(第36回日本消化器外科学会総会)
- 277 胆道内圧曲線の breaking point と cholangiovenous reflux(第34回日本消化器外科学会総会)
- 245 シミュレーションモデルによる Cholangiovenous reflux と胆道内圧の検討(第32回日本消化器外科学会総会)
- 258 マイクロトランスデューサーによる胆道内圧への波形解析の応用(第31回日本消化器外科学会総会)